NCT05749523

Brief Summary

To investigate the effects of dehydration and exercise for the urine secretion of beta2-agonists.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2013

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
8.5 years until next milestone

First Posted

Study publicly available on registry

March 1, 2023

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2023

Enrollment Period

5 months

First QC Date

July 18, 2013

Last Update Submit

February 27, 2023

Conditions

Healthy

Keywords

exercisedehydrationSalbutamolTerbutalin

Outcome Measures

Primary Outcomes (1)

  • Urine concentration of salbutamol and terbutalin

    Urine concentration of salbutamol and terbutalin

    7 days

Study Arms (1)

Exercise

OTHER

Exercise vs. non-exercise

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Exercise vs non-exercise

Exercise

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • men
  • aerobic capacity more than 50ml / min / kg
  • more than 5h training pr week

You may not qualify if:

  • smokers
  • allergy for the medicine
  • chronic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Respiratory Medicine, L, Bispebjerg Hospital,

Copenhagen, NV, 2400, Denmark

Location

MeSH Terms

Conditions

Motor ActivityDehydration

Interventions

Exercise

Condition Hierarchy (Ancestors)

BehaviorWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Vibeke Backer, Professor

    Dept of Respiratory Medicine, Bispebjerg University Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Dr. Med. Chief Physician

Study Record Dates

First Submitted

July 18, 2013

First Posted

March 1, 2023

Study Start

November 1, 2013

Primary Completion

April 1, 2014

Study Completion

September 1, 2014

Last Updated

March 1, 2023

Record last verified: 2023-02

Locations

DK(1)